Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.

MLA

Hsieh, Chih-Chia, et al. “Propensity Score-Matched Analysis Comparing the Therapeutic Efficacies of Cefazolin and Extended-Spectrum Cephalosporins as Appropriate Empirical Therapy in Adults with Community-Onset Escherichia Coli, Klebsiella Spp. and Proteus Mirabilis Bacteraemia.” International Journal of Antimicrobial Agents, vol. 48, no. 6, Dec. 2016, pp. 712–18. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2016.09.015.

APA

Hsieh, C.-C., Lee, C.-H., Hong, M.-Y., Hung, Y.-P., Lee, N.-Y., Ko, W.-C., & Lee, C.-C. (2016). Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia. International Journal of Antimicrobial Agents, 48(6), 712–718. https://doi.org/10.1016/j.ijantimicag.2016.09.015

Chicago

Hsieh, Chih-Chia, Chung-Hsun Lee, Ming-Yuan Hong, Yuan-Pin Hung, Nan-Yao Lee, Wen-Chien Ko, and Ching-Chi Lee. 2016. “Propensity Score-Matched Analysis Comparing the Therapeutic Efficacies of Cefazolin and Extended-Spectrum Cephalosporins as Appropriate Empirical Therapy in Adults with Community-Onset Escherichia Coli, Klebsiella Spp. and Proteus Mirabilis Bacteraemia.” International Journal of Antimicrobial Agents 48 (6): 712–18. doi:10.1016/j.ijantimicag.2016.09.015.